Kiora Pharmaceuticals Statistics
Total Valuation
KPRX has a market cap or net worth of $7.52 million. The enterprise value is -$11.60 million.
Important Dates
The last earnings date was Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KPRX has 3.67 million shares outstanding. The number of shares has increased by 27.45% in one year.
| Current Share Class | 3.67M |
| Shares Outstanding | 3.67M |
| Shares Change (YoY) | +27.45% |
| Shares Change (QoQ) | +9.34% |
| Owned by Insiders (%) | 2.99% |
| Owned by Institutions (%) | 20.29% |
| Float | 3.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.79, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.79 |
| Quick Ratio | 8.54 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -435.29 |
Financial Efficiency
Return on equity (ROE) is -32.58% and return on invested capital (ROIC) is -22.05%.
| Return on Equity (ROE) | -32.58% |
| Return on Assets (ROA) | -17.07% |
| Return on Invested Capital (ROIC) | -22.05% |
| Return on Capital Employed (ROCE) | -34.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$711,845 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KPRX has paid $1.43 million in taxes.
| Income Tax | 1.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.88% in the last 52 weeks. The beta is -0.75, so KPRX's price volatility has been lower than the market average.
| Beta (5Y) | -0.75 |
| 52-Week Price Change | -37.88% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 2.70 |
| Relative Strength Index (RSI) | 46.59 |
| Average Volume (20 Days) | 27,831 |
Short Selling Information
The latest short interest is 16,674, so 0.45% of the outstanding shares have been sold short.
| Short Interest | 16,674 |
| Short Previous Month | 18,296 |
| Short % of Shares Out | 0.45% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.72M |
| Operating Income | -9.34M |
| Pretax Income | -7.11M |
| Net Income | -8.54M |
| EBITDA | -9.32M |
| EBIT | -9.34M |
| Earnings Per Share (EPS) | -$2.05 |
Full Income StatementBalance Sheet
The company has $19.38 million in cash and $404,165 in debt, giving a net cash position of $18.97 million or $5.17 per share.
| Cash & Cash Equivalents | 19.38M |
| Total Debt | 404,165 |
| Net Cash | 18.97M |
| Net Cash Per Share | $5.17 |
| Equity (Book Value) | 22.41M |
| Book Value Per Share | 6.53 |
| Working Capital | 20.11M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.03 million and capital expenditures $12,405, giving a free cash flow of -$10.02 million.
| Operating Cash Flow | -10.03M |
| Capital Expenditures | 12,405 |
| Free Cash Flow | -10.02M |
| FCF Per Share | -$2.73 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.45% |
| Shareholder Yield | -27.45% |
| Earnings Yield | -115.86% |
| FCF Yield | -135.92% |
Analyst Forecast
The average price target for KPRX is $10.00, which is 387.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 387.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 48.40% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jun 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
KPRX has an Altman Z-Score of -6.36. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.36 |
| Piotroski F-Score | n/a |
